Conditioned Cocaine Reward and Nucleus Accumbens Synaptic Plasticity
条件可卡因奖励和伏核突触可塑性
基本信息
- 批准号:7485301
- 负责人:
- 金额:$ 2.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgonistAnimal ModelAnimalsBehaviorBrainCellsChronicClinical TreatmentCocaineConditionCycloserineDailyDevelopmentDrug AddictionDrug ExposureDrug Metabolic DetoxicationDrug usageElectrophysiology (science)Extinction (Psychology)GlutamatesGoalsHumanInjection of therapeutic agentKnowledgeLearningLeftMediatingMemoryMusN-Methyl-D-Aspartate ReceptorsNational Institute of Drug AbuseNatureNeuronal PlasticityNucleus AccumbensPharmaceutical PreparationsPhysiologicalPlayPliabilityPreparationPublic HealthRelapseResearchRewardsRoleRunningSignal TransductionSliceSynapsesSynaptic TransmissionSynaptic plasticityTechniquesTestingTherapeutic InterventionThinkingaddictionconditioningdesiredrug addictdrug addiction pharmacotherapydrug of abusedrug seeking behaviorexperienceinterestneuroadaptationneuromechanismpatch clamppreferencepreventresearch studyresponsesynaptic functiontherapeutic targettransmission process
项目摘要
DESCRIPTION (provided by applicant): Persistent vulnerability to relapse is a major obstacle in the clinical treatment of drug addiction. The goal of this proposal is to understand the neural mechanisms that control drug-seeking behavior, with specific reference to excitatory synaptic plasticity in the nucleus accumbens (NAc). In animal models of addiction, NAc glutamate transmission has been clearly implicated in both extinction and reinstatement of drug seeking behavior. We propose to use whole-cell patch-clamp electrophysiology in acute brain slices from mice run through a place conditioning paradigm, to study the relationship between excitatory synaptic function in NAc and the extinction and reinstatement of conditioned cocaine reward. Our preliminary studies demonstrate the feasibility of this approach, and also support a relationship between NAc synaptic strength and reinstatement. We will use the flexibility of the place conditioning paradigm to study both decreases (extinction) and increases (reinstatement) in drug-seeking behavior. We predict that reinstatement involves reduced NAc synaptic strength, and that blocking this reduction will prevent reinstatement behavior. Conversely, we expect that extinction will enhance NAc synaptic strength, and this change will be accelerated when animals are given D-cycloserine - a partial NMDA receptor agonist known to facilitate extinction. These experiments present a unique opportunity to study the relationship between synaptic plasticity and behavior in a situation where each can be-bidirectionally modulated. The results will guide the development of therapeutic interventions targeted at glutamate transmission that can reduce vulnerability to relapse in human drug addicts.
PUBLIC HEALTH RELEVANCE: Drug addiction is a major public health problem that is perpetuated when former drug addicts relapse to using drugs again. This research will help us understand changes in brain function caused by drug use that leave addicts vulnerable to relapse. It will also examine how brain function might be modified to reduce the pursuit of drugs.
描述(由申请人提供):持续易复发性是药物成瘾临床治疗的主要障碍。该提案的目标是了解控制药物寻求行为的神经机制,特别是在丘脑核(NAc)中的兴奋性突触可塑性。在成瘾的动物模型中,NAc谷氨酸传输已明确涉及寻求药物行为的消退和恢复。我们拟采用全细胞膜片钳电生理技术,在小鼠急性脑片上观察位置条件反射时,NAc兴奋性突触功能与条件可卡因奖赏消退和恢复的关系。我们的初步研究证明了这种方法的可行性,也支持NAc突触强度和恢复之间的关系。我们将使用位置条件反射范式的灵活性来研究药物寻求行为的减少(灭绝)和增加(恢复)。我们预测,恢复涉及减少NAc突触强度,并阻止这种减少将防止恢复行为。相反,我们预计,灭绝将增强NAc突触强度,当动物被给予D-环丝氨酸时,这种变化将加速-已知有助于灭绝的部分NMDA受体激动剂。这些实验提供了一个独特的机会来研究突触可塑性和行为之间的关系,在这种情况下,每一个都可以双向调制。研究结果将指导开发针对谷氨酸传输的治疗干预措施,以减少人类吸毒成瘾者复发的脆弱性。
公共卫生相关性:吸毒成瘾是一个主要的公共卫生问题,当以前的吸毒成瘾者再次吸毒时,这个问题就会持续下去。这项研究将帮助我们了解药物使用引起的大脑功能变化,这些变化使成瘾者容易复发。它还将研究如何改变大脑功能以减少对药物的追求。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick Rothwell其他文献
Patrick Rothwell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick Rothwell', 18)}}的其他基金
Genetic and Synaptic Mechanisms of State Representation Impairments in Mice
小鼠状态表征损伤的遗传和突触机制
- 批准号:
10377365 - 财政年份:2020
- 资助金额:
$ 2.62万 - 项目类别:
Genetic and Synaptic Mechanisms of State Representation Impairments in Mice
小鼠状态表征损伤的遗传和突触机制
- 批准号:
10597071 - 财政年份:2020
- 资助金额:
$ 2.62万 - 项目类别:
DAT-Regulation of Nucleus Accumbens Microcircuitry by Oxycodone Exposure and Withdrawal
羟考酮暴露和撤回对伏核微电路的 DAT 调节
- 批准号:
10218132 - 财政年份:2019
- 资助金额:
$ 2.62万 - 项目类别:
DAT-Regulation of Nucleus Accumbens Microcircuitry by Oxycodone Exposure and Withdrawal
羟考酮暴露和撤回对伏核微电路的 DAT 调节
- 批准号:
10453673 - 财政年份:2019
- 资助金额:
$ 2.62万 - 项目类别:
DAT-Regulation of Nucleus Accumbens Microcircuitry by Oxycodone Exposure and Withdrawal
羟考酮暴露和撤回对伏核微电路的 DAT 调节
- 批准号:
10671656 - 财政年份:2019
- 资助金额:
$ 2.62万 - 项目类别:
Nucleus accumbens synaptic mechanisms of opiate reward and aversion
伏隔核突触阿片奖赏和厌恶机制
- 批准号:
9215667 - 财政年份:2016
- 资助金额:
$ 2.62万 - 项目类别:
Nucleus accumbens synaptic mechanisms of opiate reward and aversion
伏隔核突触阿片奖赏和厌恶机制
- 批准号:
8820411 - 财政年份:2015
- 资助金额:
$ 2.62万 - 项目类别:
Frontostriatal Synaptic Dysfunction in a Model of Autism
自闭症模型中的额纹状体突触功能障碍
- 批准号:
8424465 - 财政年份:2012
- 资助金额:
$ 2.62万 - 项目类别:
Frontostriatal Synaptic Dysfunction in a Model of Autism
自闭症模型中的额纹状体突触功能障碍
- 批准号:
8627048 - 财政年份:2012
- 资助金额:
$ 2.62万 - 项目类别:
Frontostriatal Synaptic Dysfunction in a Model of Autism
自闭症模型中的额纹状体突触功能障碍
- 批准号:
8254823 - 财政年份:2012
- 资助金额:
$ 2.62万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 2.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 2.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 2.62万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 2.62万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 2.62万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 2.62万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 2.62万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 2.62万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 2.62万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 2.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)